2012
Apr May
US task force: End routine prostate cancer screening
REUTERS HEALTH
Sigmoidoscopy an option for colon cancer screening
Melanoma drug shows promise in early trial
Zytiga (abiraterone) shows promise in high-risk prostate cancer
Study unpicks gene changes behind breast cancer
Aveo kidney cancer drug more tolerated than sorafenib (Nexavar)
Doctors often unfamiliar with long-term chemo risks
Promising early results from drug combo for advanced multiple myeloma
Fish tied to lower colon cancer risk: study
Take second-look at node-negative or DCIS breast pathology: study
High-risk breast cancer may recur at similar rates after lumpectomy and mastectomy
U.S. may speed approval of 'breakthrough' drugs
Women with melanoma fare better than men
Surgery alone effective for low-risk neuroblastoma
FDA says number of new U.S. drug shortages down
Cytogenetics predict long-term survival with multiple myeloma
More women need breasts removed after brachytherapy
Mammograms may be worth risks for some in their 40s
NEWS PROVIDED BY
CURE Media Group About Us | Contact Us | CMG Corporate | Cancer Continuum | Press | FAQs | Write for CURE
Advertise Media Kit | Reprints
Manage Subscription Services | Newsletters | Join the CURE Survey Panel | My Account
Legal Licensing | Terms of Use | Privacy Policy
© 2012 CURE Media Group. All rights reserved. SitemapCURE does not provide medical, diagnostic, or treatment advice.
